CD8A and neoplasm: Although our study showed that the clinical significance of TMIT analysis based on RNA data was not obvious, TMIT classification by an IHC analysis, especially according to the distribution of CD8+ T cells in the tumor islets or stroma, allowed us to identify TMIT with differential impact on clinical outcome.